What's coming? Pazdur, Marks and Woodcock discuss FDA changes

Three of the FDA’s directors — Richard Pazdur, Peter Marks and Janet Woodcock — took the stage Wednesday at Prevision Policy’s Biopharma Congress to discuss all things FDA: from why the agency is viewed more positively now than in the past to what needs to happen in each of their centers.